Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer.

× No keyword cloud information.

11 in total

1. Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.

Authors: E Dublin; A Hanby; N K Patel; R Liebman; D Barnes
Journal: Am J Pathol Date: 2000-10 Impact factor: 4.307

2. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.

Authors: A H Ree; K Bjørnland; N Brünner; H T Johansen; K B Pedersen; A O Aasen; O Fodstad
Journal: Clin Exp Metastasis Date: 1998-04 Impact factor: 5.150

3. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.

Authors: S Shetty; S Idell
Journal: Mol Cell Biochem Date: 1999-09 Impact factor: 3.396

4. Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells.

Authors: G Xiao; Y E Liu; R Gentz; Q A Sang; J Ni; I D Goldberg; Y E Shi
Journal: Proc Natl Acad Sci U S A Date: 1999-03-30 Impact factor: 11.205

Review 5. The role of the integrin vitronectin receptor, alpha v beta 3 in melanoma metastasis.

Authors: J Nip; P Brodt
Journal: Cancer Metastasis Rev Date: 1995-09 Impact factor: 9.264

6. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.

Authors: C Gilles; M Polette; P Birembaut; N Brünner; E W Thompson
Journal: Clin Exp Metastasis Date: 1997-09 Impact factor: 5.150

7. Integrin alpha6 cleavage: a novel modification to modulate cell migration.

Authors: Sangita C Pawar; Manolis C Demetriou; Raymond B Nagle; G Tim Bowden; Anne E Cress
Journal: Exp Cell Res Date: 2007-01-17 Impact factor: 3.905

8. Development of a Mammalian suspension culture for expression of active recombinant human urokinase-type plasminogen activator.

Authors: Erica Atkins; Stephanie Zamora; Britny J Candia; Amy Baca; Robert A Orlando
Journal: Cytotechnology Date: 2005-09 Impact factor: 2.058

9. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.

Authors: S M Pulukuri; B Gorantla; J A Knost; J S Rao
Journal: Oncogene Date: 2009-06-08 Impact factor: 9.867

10. Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1.

Authors: Jennifer C Carter; Frank C Church
Journal: PPAR Res Date: 2009-08-06 Impact factor: 4.964